1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Central America Pharmaceuticals and Healthcare Report Q3 2015

Central America Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 58 pages

Includes 3 FREE quarterly updates

BMI View:
Favourable tax incentives, continued demand for both generic and patented medicines, andregional anti-counterfiet measures solidify Central America's revenue generating opportunities formultinational pharmaceutical companies in coming years. Despite political instability in some areas of theregion, Central America's medicine consumption will continue to grow in 2015.
Headline Expenditure Projections
- Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.1%. Our forecast has been maintainedsince Q215.- Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.1%. Our forecast has been revised upwardssince Q215 due to revised historical data.

Table Of Contents

Central America Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View ...... 7
SWOT ............ 9
SWOT .............. 9
Industry Forecast ..... 10
Pharmaceutical Market Forecast ....... 10
Table: Central America Pharmaceutical Sales, Historic Data And Forecasts . 12
Guatemala ..... 12
Table: Guatemala Pharmaceutical Sales Forecasts . . . . 12
Costa Rica ..... 13
Table: Costa Rica Pharmaceutical Sales Forecasts . . . . 13
El Salvador .... 13
Table: El Salvador Pharmaceutical Sales Forecasts . . . 14
Honduras ...... 14
Table: Honduras Pharmaceutical Sales Forecasts . . . . . 14
Panama ......... 14
Table: Panama Pharmaceutical Sales Forecasts . 15
Nicaragua ..... 15
Table: Nicaragua Pharmaceutical Sales Forecasts . . . . 15
Healthcare Market Forecast ............. 16
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts 17
Guatemala ..... 17
Table: Guatemala Healthcare Expenditure Forecasts . 18
Costa Rica ..... 18
Table: Costa Rica Healthcare Expenditure Forecasts . 18
El Salvador .... 18
Table: El Salvador Healthcare Expenditure Forecasts 19
Panama ......... 19
Table: Panama Healthcare Expenditure Forecasts . . . . 19
Honduras ...... 19
Table: Honduras Healthcare Expenditure Forecasts . . 20
Nicaragua ..... 20
Table: Nicaragua Healthcare Expenditure Forecasts . . 20
Pharmaceutical Trade Forecast ........ 21
Guatemala ..... 23
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn) . . . . . 23
Costa Rica ..... 23
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn) . . . . . 23
El Salvador .... 24
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn) . . . . 24
Panama ......... 24
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn) . . 25
Honduras ...... 25
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn) 25
Nicaragua ..... 26
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn) 26
Industry Risk Reward Ratings 27
Americas Risk/Reward Index ............ 27
Central America Risk/Reward Index ... 32
Rewards ........ 33
Risks ............. 33
Industry Trends And Developments ..... 34
Epidemiology . 34
Healthcare Sector .......... 35
Guatemala ..... 36
Costa Rica ..... 37
El Salvador .... 38
Panama ......... 39
Honduras ...... 39
Nicaragua ..... 40
Clinical Trials 41
Regulatory Development ........ 43
Intellectual Property Regime ........... 43
Costa Rica ..... 44
El Salvador .... 45
Honduras ...... 45
Nicaragua ..... 46
Guatemala ..... 46
Competitive Landscape .......... 47
Company Profile ....... 48
Ancalmo Internacional ..... 48
Donovan Werke 50
Glossary ..... 52
Methodology ............. 54
Pharmaceutical Expenditure Forecast Model .... 54
Healthcare Expenditure Forecast Model ........... 54
Notes On Methodology .... 55
Risk/Reward Index Methodology ...... 56
Index Overview .............. 57
Table: Pharmaceutical Risk/Reward Index Indicators . 57
Indicator Weightings ...... 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.